Corpus Intelligence IC Memo — MERCY HEALTH-WILLARD HOSPITAL LLC 2026-04-26 12:47 UTC
IC Memo — MERCY HEALTH-WILLARD HOSPITAL LLC
Investment Committee Memorandum | OH | 20 beds | Grade C | EBITDA uplift $2.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MERCY HEALTH-WILLARD HOSPITAL LLC

CCN 361310 | HURON, OH | 20 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MERCY HEALTH-WILLARD HOSPITAL LLC is a 20-bed rural/critical access in HURON, OH with $28.0M in net patient revenue and a -1.7% operating margin. The hospital serves a payer mix of 50.0% Medicare, 1.0% Medicaid, and 49.1% commercial.

Thesis: Turnaround. Our ML models identify $2.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.7% to 5.6% (+736bps).

Net Revenue HCRIS$28.0M
Current EBITDA COMPUTED$-484K
Operating Margin COMPUTED-1.7%
Occupancy HCRIS23.0%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS35.4%
Distress Probability ML54.6%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
69
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -1.7% places it below the state median. Among 69 size-comparable peers (10-40 beds), the median margin is -3.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (10-40), prioritizing same-state peers. 69 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MERCY HEALTH-WILLARD HOSPITAL (Target)OH20$28.0M-1.7%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
GALION COMMUNITY HOSPITALOH25$128.2M16.6%
MARY RUTAN HOSPITALOH39$113.0M-12.5%
MERCY HEALTH-TIFFIN HOSPITAL OH35$103.0M18.1%
JOINT TOWNSHIP DISTRICT MEMORIOH33$95.6M9.3%
FULTON COUNTY HEALTH CENTEROH25$95.2M-7.4%
UH SAMARITAN MEDICAL CENTEROH39$88.9M-3.5%
MEMORIAL HOSPITALOH31$79.9M4.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$587K+210bp18mo
Cost to Collect4.5%2.5%$559K+200bp12mo
Denial Rate Reduction12.0%6.5%$553K+198bp12mo
A/R Days Reduction5200.0%3800.0%$340K+122bp9mo
Clean Claim Rate88.0%96.0%$18K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$587K
Cost to Collect
$559K
Denial Rate Reduction
$553K
A/R Days Reduction
$340K
Clean Claim Rate
$18K
Total EBITDA Uplift$2.1M
Current EBITDA$-484K
+ RCM Uplift+$2.1M
Pro Forma EBITDA$1.6M
Current Margin-1.7%
Pro Forma Margin5.6%
WC Released (1x)$1.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-745K$17.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-745K$18.9M0.00x-100.0%
Bull Case9.0x11.0x$-670K$25.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-670K$27.5M0.00x-100.0%
Bear Case11.0x10.0x$-819K$7.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-819K$7.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 23.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 69 hospitals with 10-40 beds
  • Same-state prioritization (n=70)
  • Comp margins: P25=-12.5% / P50=-3.4% / P75=13.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.